Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer
Isoform 2 of tight junction protein claudin-18 (CLDN18.2) is a potential target for gastric cancer treatment. A treatment targeting CLDN18.2 has shown promising results in gastric cancer. We investigated the clinical significance of CLDN18.2 and other cell-adherens junction molecules (Rho GTPase-act...
Saved in:
Published in | Journal of gastric cancer Vol. 20; no. 4; pp. 408 - 420 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Gastric Cancer Association
01.12.2020
대한위암학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!